Personal tools

MCL coexpression mm9:1191: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001017!4.82e-29!73;UBERON:0001016!8.76e-29!75;UBERON:0002346!6.37e-28!64;UBERON:0003075!6.37e-28!64;UBERON:0007284!6.37e-28!64;UBERON:0004121!3.62e-27!95;UBERON:0000924!3.62e-27!95;UBERON:0006601!3.62e-27!95;UBERON:0000073!3.46e-25!54;UBERON:0010371!9.45e-25!73;UBERON:0001049!5.92e-23!52;UBERON:0005068!5.92e-23!52;UBERON:0006241!5.92e-23!52;UBERON:0007135!5.92e-23!52;UBERON:0000955!8.62e-19!47;UBERON:0006238!8.62e-19!47;UBERON:0002616!7.89e-18!46;UBERON:0002020!2.25e-17!34;UBERON:0003056!2.31e-17!49;UBERON:0010314!1.35e-16!92;UBERON:0003080!1.13e-14!40;UBERON:0002780!7.92e-14!39;UBERON:0001890!7.92e-14!39;UBERON:0006240!7.92e-14!39;UBERON:0003528!3.42e-13!29;UBERON:0002791!3.42e-13!29;UBERON:0001893!3.42e-13!29;UBERON:0003076!2.25e-09!12;UBERON:0003057!2.25e-09!12;UBERON:0002420!5.05e-08!8;UBERON:0007245!5.05e-08!8;UBERON:0010009!5.05e-08!8;UBERON:0010011!5.05e-08!8;UBERON:0000454!5.05e-08!8;UBERON:0000956!2.82e-07!21;UBERON:0001869!2.82e-07!21;UBERON:0000203!2.82e-07!21
|ontology_enrichment_uberon=UBERON:0001017!4.82e-29!73;UBERON:0001016!8.76e-29!75;UBERON:0002346!6.37e-28!64;UBERON:0003075!6.37e-28!64;UBERON:0007284!6.37e-28!64;UBERON:0004121!3.62e-27!95;UBERON:0000924!3.62e-27!95;UBERON:0006601!3.62e-27!95;UBERON:0000073!3.46e-25!54;UBERON:0010371!9.45e-25!73;UBERON:0001049!5.92e-23!52;UBERON:0005068!5.92e-23!52;UBERON:0006241!5.92e-23!52;UBERON:0007135!5.92e-23!52;UBERON:0000955!8.62e-19!47;UBERON:0006238!8.62e-19!47;UBERON:0002616!7.89e-18!46;UBERON:0002020!2.25e-17!34;UBERON:0003056!2.31e-17!49;UBERON:0010314!1.35e-16!92;UBERON:0003080!1.13e-14!40;UBERON:0002780!7.92e-14!39;UBERON:0001890!7.92e-14!39;UBERON:0006240!7.92e-14!39;UBERON:0003528!3.42e-13!29;UBERON:0002791!3.42e-13!29;UBERON:0001893!3.42e-13!29;UBERON:0003076!2.25e-09!12;UBERON:0003057!2.25e-09!12;UBERON:0002420!5.05e-08!8;UBERON:0007245!5.05e-08!8;UBERON:0010009!5.05e-08!8;UBERON:0010011!5.05e-08!8;UBERON:0000454!5.05e-08!8;UBERON:0000956!2.82e-07!21;UBERON:0001869!2.82e-07!21;UBERON:0000203!2.82e-07!21
|tfbs_overrepresentation_for_novel_motifs=1.95401,0.660133,1.05921,0.480627,0.299217,0.495263,0.587291,0.206208,0.616096,0.219671,0.542749,0.575086,0.206435,0.599731,0.315771,0,0.795315,0.291368,0.19222,0.112498,0.374752,0.08187,0.598814,0.29769,0.419327,0.62766,0.184473,0.516511,0.344372,0.446946,0.50223,0.897561,0.289148,0.498917,0.316253,0.0235321,0.279977,1.40099,0.258564,0.230656,0.295233,0.507468,0.0742755,0.317766,0.277561,0.469348,0.714592,0.532496,0.0609361,0.347313,0.777641,0.654933,0.431711,1.04034,1.0579,0.606984,0.356236,0.56214,0.176152,0.604914,2.03558,0.664501,0.226529,0.766235,0.618279,0.807219,1.19497,1.54543,0.872612,1.39786,0.392734,0.21183,0.293368,1.09164,1.55661,0.159969,0.963958,1.67636,0.859987,0.378988,1.14907,0.812889,0.663039,0.580284,0.975495,0.960306,0.042613,0.447265,0.719558,1.70793,1.26498,0.980512,0.910485,0.305079,0.254625,0.668513,0.203879,0.913319,0.71485,0.127063,0.280055,0.897279,1.02279,0.778243,1.82972,0.507021,0.837607,0.528416,0.383871,1.74385,0.430942,1.02459,0.380122,0.547992,1.27206,0.796976,0.735764,0.484437,0.796633,0.276329,1.09707,1.76329,0.629509,0.702145,1.32639,0.863723,0.595563,0.903645,1.19345,0.308038,1.00568,0.473246,1.16374,0.620831,1.29374,0.275843,0.446555,0.508896,1.24438,2.07659,1.67603,1.19971,0.641722,0.908128,0.770616,0.507927,0.717753,2.03691,0.448938,0.300961,0.452587,0.545091,1.04192,0.681896,0.619892,1.12411,0.655955,0.874089,0.435579,0.446272,1.25393,0.974632,0.864173,0.428662,0.767269,0.612377,0.278874,0.573477,0.227149
}}
}}

Revision as of 19:32, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr2:90725578..90725583,+p13@C1qtnf4
Mm9::chr3:109945914..109945928,-p2@Ntng1
Mm9::chr3:109946431..109946443,-p8@Ntng1
Mm9::chr3:109946598..109946609,-p5@Ntng1
Mm9::chr3:109946616..109946633,-p3@Ntng1
Mm9::chr3:109946704..109946760,-p1@Ntng1
Mm9::chr8:121970822..121970847,+p2@Necab2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0017000antibiotic biosynthetic process0.0153365824918586
GO:0016999antibiotic metabolic process0.0153365824918586
GO:0017144drug metabolic process0.0153365824918586
GO:0046658anchored to plasma membrane0.0202376340836703
GO:0031225anchored to membrane0.0202376340836703



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
central nervous system4.82e-2973
nervous system8.76e-2975
neurectoderm6.37e-2864
neural plate6.37e-2864
presumptive neural plate6.37e-2864
ectoderm-derived structure3.62e-2795
ectoderm3.62e-2795
presumptive ectoderm3.62e-2795
regional part of nervous system3.46e-2554
ecto-epithelium9.45e-2573
neural tube5.92e-2352
neural rod5.92e-2352
future spinal cord5.92e-2352
neural keel5.92e-2352
brain8.62e-1947
future brain8.62e-1947
regional part of brain7.89e-1846
gray matter2.25e-1734
pre-chordal neural plate2.31e-1749
structure with developmental contribution from neural crest1.35e-1692
anterior neural tube1.13e-1440
regional part of forebrain7.92e-1439
forebrain7.92e-1439
future forebrain7.92e-1439
brain grey matter3.42e-1329
regional part of telencephalon3.42e-1329
telencephalon3.42e-1329
posterior neural tube2.25e-0912
chordal neural plate2.25e-0912
basal ganglion5.05e-088
nuclear complex of neuraxis5.05e-088
aggregate regional part of brain5.05e-088
collection of basal ganglia5.05e-088
cerebral subcortex5.05e-088
cerebral cortex2.82e-0721
cerebral hemisphere2.82e-0721
pallium2.82e-0721


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}